COCRYSTAL PHARMA ANNOUNCES LAST SUBJECT DOSED IN PHASE 1B HUMAN CHALLENGE STUDY EVALUATING CDI-988 FOR NOROVIRUS PREVENTION AND TREATMENT

Reuters · 2d ago

Please log in to view news